CLBCore Laboratories Inc. /DE/(CLB)Stock Analysis

AI analysis on 2,800+ stocks →
EnergyNYSE
Institutional-grade research for retail investors
SEC EDGAR: CIK 1958086CLB stock profile & AI dashboard →

13F Pro Quality Score

44.0/100

Rank #1,788 of 2,879 stocks

View Energy peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

28.9/100

Profitability

47.6/100

Balance Sheet

65.0/100

Earnings Quality

19.8/100

Free Cash Flow

48.2/100

Institutional Flow

54.9/100

Revenue Scale

37.1/100

Dilution Risk

49.2/100

CLB Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Core Laboratories Inc. /DE/ (CLB), a Energy sector company. 13F Pro's AI-powered ranking engine scores CLB at 44.0/100 on a 32-signal composite quality model, placing it at rank #1,788 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include earnings quality (19.8) and revenue growth (28.9), which score below median versus the broader universe. Shareholder dilution risk is elevated at 49.2/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), Core Laboratories Inc. /DE/ reports quarterly revenue of $121.8M, net income of $-789.0K, free cash flow of $517.0K. Top institutional holders of CLB by reported 13-F value include ARIEL INVESTMENTS,, BlackRock,, DISCIPLINED GROWTH INVESTORS /MN, based on the most recent SEC filings. CLB trades on the NYSE exchange and files with the SEC under CIK 1958086. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CLB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Core Laboratories Inc. /DE/ directly from SEC EDGAR.

Revenue

Q1 2026

$121.8M

Net Income

Q1 2026

$-789.0K

Free Cash Flow

Q1 2026

$517.0K

D/E Ratio

Q1 2026

0.44

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+7.0% YoY
$523.8MFY 2024
FY20 FY22 $489.7MFY24 $523.8M

Net Income

+61.4% YoY
$31.4MFY 2024
FY20 FY22 $19.5MFY24 $31.4M

Operating Income

+41.0% YoY
$58.6MFY 2024
FY20 FY22 $41.5MFY24 $58.6M

EPS (Diluted)

+57.1% YoY
$0.66FY 2024
FY20 FY22 $0.42FY24 $0.66

Total Assets

+2.1% YoY
$590.4MFY 2024
FY20 FY22 $578.4MFY24 $590.4M

Total Debt

-26.9% YoY
$128.0MFY 2024
FY20 FY22 $175.0MFY24 $128.0M

Op. Cash Flow

+125.9% YoY
$56.4MFY 2024
FY20 FY22 $25.0MFY24 $56.4M

Get alerted when CLB's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Core Laboratories Inc. /DE/ including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of CLB

Put CLB on your watchlist

Track score changes the day Core Laboratories Inc. /DE/ files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is CLB a good stock to buy?

13F Pro's AI-powered analysis of Core Laboratories Inc. /DE/ (CLB) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Energy sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CLB are available on the CLB stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own CLB?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CLB. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Core Laboratories Inc. /DE/'s investment landscape.